跳至主要内容
临床试验/ITMCTR2000003577
ITMCTR2000003577招募中4 期

Prevention and Treatment of Recurrence and Metastasis of Hepatocellular Carcinoma after Operation with Ganyanshu Decoctions

onghua Hospital, Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • (1) With reference to the 2018 edition of the systems of primary liver cancer diagnosis and treatment guidelines and the 2018 edition of the diagnosis and treatment of hepatocellular carcinoma (HCC) merger portal venous tumor emboli multidisciplinary China expert consensus, the eighth edition of the AJCC TNM staging system standards and PVTT program classification, selection of stage Ia, Ib merge each type of portal venous tumor emboli and II - stage IIIb (and/or merge each type of portal venous tumor emboli) of postoperative patients with liver cancer;
  • (2) Estimated survival >=3 months;
  • (3) Physical condition (ECOG) score <=2;
  • (4) Aged 18 to 80 years old;
  • (5) Patients voluntarily participate in the study of this project and sign informed consent.

排除标准

  • (1) Patients with a history of other malignant tumors;
  • (2) having a serious or uncontrolled medical condition or an infected person;
  • (3) Participating in other clinical studies or participating in other clinical studies within 1 month.

研究者

发起方
onghua Hospital, Shanghai University of Traditional Chinese Medicine

相似试验

Prevention and Treatment of Recurrence and... | 临床试验